Hot Papers

S.J. Tapscott, R.L. Davis, M.J. Thayer, P.-F. Cheng, et al., "MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts," Science, 242, 405-11, 21 October 1988. Stephen Tapscott (Fred Hutchinson Cancer Research Center, Seattle): "This article reported our initial effort to characterize the MyoD protein. The two major points of the article are: (1) MyoD is a phosphorylated nuclear protein present in myoblasts and myotubes; and (2) The previously recogniz

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

S.J. Tapscott, R.L. Davis, M.J. Thayer, P.-F. Cheng, et al., "MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts," Science, 242, 405-11, 21 October 1988.

Stephen Tapscott (Fred Hutchinson Cancer Research Center, Seattle): "This article reported our initial effort to characterize the MyoD protein. The two major points of the article are: (1) MyoD is a phosphorylated nuclear protein present in myoblasts and myotubes; and (2) The previously recognized region of similarity between MyoD and Myc is both necessary and sufficient for the ability of MyoD to activate the myogenic program. It has now become evident that MyoD is a member of a potentially very large family of proteins that share this region of similarity, which has been referred to as a helix-loop-helix motif. Many of these related proteins have been identified by sequence homology, and their role in differentiation of various lineages has been ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies